Correlation Between Cognition Therapeutics and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and INmune Bio, you can compare the effects of market volatilities on Cognition Therapeutics and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and INmune Bio.
Diversification Opportunities for Cognition Therapeutics and INmune Bio
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cognition and INmune is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and INmune Bio go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and INmune Bio
Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the INmune Bio. In addition to that, Cognition Therapeutics is 1.35 times more volatile than INmune Bio. It trades about -0.03 of its total potential returns per unit of risk. INmune Bio is currently generating about 0.0 per unit of volatility. If you would invest 771.00 in INmune Bio on August 30, 2024 and sell it today you would lose (282.00) from holding INmune Bio or give up 36.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognition Therapeutics vs. INmune Bio
Performance |
| Timeline |
| Cognition Therapeutics |
| INmune Bio |
Cognition Therapeutics and INmune Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and INmune Bio
The main advantage of trading using opposite Cognition Therapeutics and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.| Cognition Therapeutics vs. Bright Minds Biosciences | Cognition Therapeutics vs. HP Inc | Cognition Therapeutics vs. Intel | Cognition Therapeutics vs. Chevron Corp |
| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |